Skip to main content

legal_action

Capricor Therapeutics Faces Securities Fraud Suit Over Deramiocel BLA

Los Angeles – September 10, 2026 -- Schall, Brown & Schwartz LLP (SBS) has issued a reminder to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR) of a securities class action lawsuit alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The lead plaintiff deadline is set for September 28, 2026.

Lawsuit covers CAPR shares purchased between December 17, 2025 and July 26, 2026

The class action targets investors who purchased Capricor shares during this roughly seven-month window. Appointment as lead plaintiff is not a prerequisite for shareholders to participate in any eventual recovery.

Regeneron Sued Over Failed Melanoma Trial, $11B Market Cap Loss

Image
Regeneron Sued Over Failed Melanoma Trial, $11B Market Cap Loss

San Francisco – September 10, 2026 -- Hagens Berman Sobol Shapiro LLP has filed a securities class action against Regeneron Pharmaceuticals (NASDAQ: REGN) after the failure of a Phase 3 melanoma trial wiped out $11 billion in market capitalization. The suit covers investors who purchased Regeneron shares between August 1, 2025, and May 15, 2026, with a lead plaintiff deadline set for September 14, 2026.

Regeneron's Fianlimab-Libtayo combination failed to hit its primary endpoint

The complaint centers on Regeneron's Phase 3 trial testing Fianlimab combined with Libtayo as a first-line treatment for metastatic or locally advanced melanoma, a therapy management repeatedly called a "potential blockbuster." On May 15, 2026, Regeneron disclosed the trial did not reach statistical significance on its primary endpoint of progression-free survival.

PROCEPT BioRobotics Hit With Securities Suit Over Handpiece Sales

Image
PROCEPT BioRobotics Hit With Securities Suit Over Handpiece Sales

San Francisco – September 10, 2026 -- A securities class action has been filed against PROCEPT BioRobotics Corporation (NASDAQ: PRCT), alleging the company inflated handpiece sales through an undisclosed bulk-discount program that pulled forward demand and masked deteriorating customer inventory levels. Law firm Hagens Berman Sobol Shapiro LLP is representing investors who purchased PROCEPT stock between February 28, 2024 and February 25, 2026, with a lead plaintiff deadline set for September 22, 2026.

Cogent Communications Hit With Securities Suit Over Wavelength Backlog

Image
Cogent Communications Hit With Securities Suit Over Wavelength Backlog

San Francisco – September 10, 2026 -- Hagens Berman Sobol Shapiro LLP has filed a securities class action against Cogent Communications Holdings (NASDAQ: CCOI), alleging the company misrepresented its optical wavelength "backlog" as a reliable indicator of revenue growth between February 29, 2024 and May 1, 2026.

Lawsuit targets Cogent's wavelength backlog disclosures as misleading investors

The complaint alleges Cogent's wavelength backlog was largely illusory, with customers unable or unwilling to accept delivery even when the company could provision the wavelengths. Plaintiffs claim this misrepresented actual customer demand and inflated the company's growth narrative.

Wix Faces Securities Suit After AI Costs Erase $1.1B in Market Value

Image
Wix Faces Securities Suit After AI Costs Erase $1.1B in Market Value

San Francisco – September 10, 2026 -- Wix.com Ltd. (NASDAQ: WIX) is now the target of a securities class action following a 27% plunge in its share price after the company disclosed Q1 2026 results showing operating expenses had spiked 46% year-over-year. The case, Yappi v. Wix.com Ltd., et al., No. 26-cv-08852, was filed in the U.S. District Court for the Northern District of Illinois and seeks to represent investors who bought Wix securities between February 19, 2025 and May 12, 2026.

DNOW Faces Securities Suit Over MRC Global ERP Failures Before Merger

Image
DNOW Faces Securities Suit Over MRC Global ERP Failures Before Merger

San Francisco – September 10, 2026 -- DNOW Inc. (NYSE: DNOW) shares plunged 19% in a single session after the company disclosed that persistent ERP failures at newly acquired MRC Global Inc. had crushed revenues, triggering a securities class action lawsuit filed by Hagens Berman.

The suit centers on proxy materials tied to DNOW's merger with MRC Global, alleging management misrepresented the readiness of MRC's enterprise resource planning system ahead of a shareholder vote.

Shareholders who held stock as of August 5, 2025 form the proposed class

The defined investor class covers DNOW common stockholders as of the August 5, 2025 record date, who were entitled to vote at the company's September 9, 2025 special meeting approving the MRC Global merger. The lead plaintiff deadline is set for October 2, 2026.

Papa John's Hit With Securities Class Action Over Turnaround Claims

Image
Papa John's Hit With Securities Class Action Over Turnaround Claims

New York – September 10, 2026 -- Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Papa John's International, Inc. (NASDAQ: PZZA) and certain company officers, alleging violations of federal securities laws.

Lawsuit covers investors who bought PZZA shares over a one-year window

The class period spans August 7, 2025 to August 5, 2026. The complaint targets all persons and entities that purchased or otherwise acquired Papa John's securities during that stretch.

Datavault AI Faces Securities Fraud Suit, Oct. 5 Deadline Looms

Image
Datavault AI Faces Securities Fraud Suit, Oct. 5 Deadline Looms

Los Angeles – -- Investors who purchased Datavault AI, Inc. securities between September 4, 2024 and October 30, 2025 have until October 5, 2026 to seek lead plaintiff status in a newly filed securities fraud class action, according to Glancy Prongay Wolke & Rotter LLP.

Complaint alleges Datavault AI concealed material facts to inflate share price

The class action complaint claims Datavault AI and named defendants made materially false or misleading statements and omitted adverse facts about the company's business, operations and prospects throughout the 13-month class period. The suit alleges the conduct artificially inflated and maintained the market price of Datavault AI securities, inducing investors to purchase shares and options at inflated valuations.